H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $49
Analysts' Top Healthcare Picks: TG Therapeutics (TGTX), Boston Scientific (BSX)
TG Therapeutics Analyst Ratings
HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $49 Price Target
Goldman Sachs Maintains Neutral on TG Therapeutics, Raises Price Target to $20
Goldman Sachs Maintains TG Therapeutics(TGTX.US) With Hold Rating, Raises Target Price to $20
Maintaining Hold on TG Therapeutics Amidst Positive Performance and Ongoing Uncertainties
TG Therapeutics Analyst Ratings
B.Riley Financial Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $34
H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $49
Bullish on Briumvi: Buy Rating Affirmed for TG Therapeutics Amid Strong Financials and Market Adoption
TG Therapeutics Analyst Ratings
Sell Rating on TG Therapeutics: Caution Amid Competitive Threats and Decelerating Prescription Growth
Hold Rating on TG Therapeutics Amidst Strong Briumvi Launch and Competitive Market Pressures
Briumvi's Market Share Growth and TG Therapeutics' Strong Financial Outlook Justify Buy Rating
Bank of America Securities Keeps Their Sell Rating on TG Therapeutics (TGTX)
TG Therapeutics Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), TG Therapeutics (TGTX)
TG Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (ALHC), TG Therapeutics (TGTX) and Amicus (FOLD)